Sign In

Laurie Myers

Director, ESG Strategy and Engagement at Merck

Laurie A. Myers, Ph.D., is the Chief Operating Officer at Cingulate Therapeutics, a role she has held since October 2017. She is also a founding member of the company’s Board of Directors, which she served on from June 2013 to June 2018. Dr. Myers has extensive experience in the pharmaceutical industry, having worked in various leadership positions across research, development, marketing, and commercialization. Her therapeutic expertise includes areas such as neurology/psychiatry, cardiovascular disease/thrombosis, and osteoarthritis.1

Before joining Cingulate Therapeutics, Dr. Myers held significant roles at leading pharmaceutical companies including Novartis, DuPont, Pfizer, and Sanofi. Her accomplishments in these positions have earned her recognition such as the Health 2.0 Outstanding Leadership Award in 2022 and being named among the Top 100 Brand Champions by Pharma Voice.1

In addition to her corporate roles, Dr. Myers is actively involved in community service and supports organizations that address social and academic needs for at-risk youth in Kansas City. She joined the Board of Directors for Youth R.I.S.E Kansas City in 2021.1

Dr. Myers holds a Bachelor of Science and a Master of Science in Biology and Biochemistry from the University of Scranton, a Ph.D. in Toxicology from Rutgers University, and an MBA in Pharmaceutical Marketing from Saint Joseph's University.1

Highlights

Jul 24 · linkedin

Shout out to Dr. Vince Clinical Research in Kansas City for their ongoing support of Cingulate's clinical research program and progress. Happy to give a reference for anyone interested.

https://drvince.com

Jun 6 · linkedin

This week, I had the privilege of attending an Intensive Bioethics Course organized by the Kennedy Institute of Ethics and the Edmund D. Pellegrino Center for Bioethics. The program delved into contemporary topics such as the convergence of Artificial Intelligence and Bioethics. Noteworthy lectures, including one by Dr Anthony Fauci, and the enthusiasm of attendees fostered a rich environment for learning and discourse.

I recommend this course to anyone intrigued by emerging themes in healthcare, clinical, and scientific bioethics.

Related Questions

What are Laurie Myers' main responsibilities at Cingulate Therapeutics?
How did Laurie Myers transition from Merck to Cingulate Therapeutics?
What are some of Laurie Myers' notable achievements in the pharmaceutical industry?
What is Laurie Myers' educational background?
How has Laurie Myers contributed to the local community in Kansas City?
Laurie Myers
Laurie Myers, photo 1
Laurie Myers, photo 2
Add to my network

Experience

Director, ESG Strategy and Engagement at Merck (2022 - Present)
Various roles at Merck, including Director of Global Health Literacy and Oncology Health Equity (2011 - Present)

Education

MBA in Health Care Management from University of Pennsylvania - The Wharton School (1997 - 1999), BA in Psychology, Magna cum Laude from Yale University (1989 - 1994)

Location

Kansas City, Kansas